Decline in hepatitis e virus antibody prevalence in the United States from 1988-1994 to 2009-2010

Journal of Infectious Diseases

Volumn 211, Issue 3, 2015, Pages 366-373

  Teshale, Eyasu H ^a   Denniston, Maxine M ^a   Drobeniuc, Jan ^a   Kamili, Saleem ^a   Chong Gee, Teo ^a   Holmberg, Scott D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

anti HEV; Hepatitis E virus; IgG assay; NHANES; seroprevalence

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; HEPATITIS ANTIBODY; IMMUNOGLOBULIN G;

ADULT; AGE; AGED; AMERICAN; ANTIBODY DETECTION; ANTIBODY TITER; BLACK PERSON; CAUCASIAN; CHILD; COCAINE DEPENDENCE; CONTROLLED STUDY; DEMOGRAPHY; ETHNICITY; FAMILY SIZE; FEMALE; FOOD INTAKE; GENDER; HEPATITIS E VIRUS; HUMAN; LEAFY VEGETABLE; LETTUCE; MALE; MEXICAN AMERICAN; MIDDLE AGED; MILITARY SERVICE; POVERTY; PRESCHOOL CHILD; PROCESSED MEAT; REVIEW; SEROPREVALENCE; UNITED STATES; WATER SUPPLY; ADOLESCENT; ETHNIC GROUP; HEPATITIS E; IMMUNOLOGY; NUTRITION; PREVALENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; ETHNIC GROUPS; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84922569761     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu466     Document Type: Review

References (30)

1. Teshale EH, Hu D, Holmberg SD. The two faces of hepatitis E. Clin infect Dis 2010; 51:328-34.
2. Faber M, Wenzel J, Jilg W, et al. Hepatitis E virus seroprevalence among adults, Germany. Emer Inf Dis 2012; 10:1654-7.
3. Teshale EH, Howard CM, Grytdal SP, et al. Evidence of person-to-person transmission of hepatitis E virus during large outbreak in Northern Uganda. Clin Infect Dis 2010; 50:1006-10.
4. Aggarwal R, Jameel S. Hepatitis E. Hepatology 2011; 54:2218-26.
5. Miyashita K, Kang JH, Saga A, et al. Three cases of acute or fulminant hepatitis E caused by ingestion of pork meat and entrails in Hokkaido, Japan: Zoonotic food-borne transmission of hepatitis E virus and public health concerns. Hepatol Res 2012; 42:870-8.
6. Teo CG. Much meat, much malady: changing perceptions of the epidemiology of hepatitis E. Clin Microbiol Infect 2010; 16:24-32.
7. Colson P, Borentain P, Queyriaux B, et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010; 202:825-34.
8. Mizuo H, Yakazi Y, Sugawara K, et al. Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan. J Med Virol 2005; 76:341-9.
9. Crossan C, Baker PJ, Craft J, et al. Hepatitis E virus genotype 3 in shellfish, United Kingdom. Emerg Infect Dis 2013; 18:2085-7.
10. Said B, Ijaz S, Kafatos G, et al. Hepatitis E outbreak on cruise ship. Emerg Infect Dis 2009; 15:1738-44.
11. Kuniholm MH, Purcell RH, McQuilllan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 2009; 200:48-56.
12. Thomas DL, Yarbough PO, Vlahov D, et al. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol 1997; 35:1244-7.
13. Drobeniuc J, Favorov MO, Shapiro CN, et al. Hepatitis E virus antibody seroprevalence among persons who work with swine. J Infect Dis 2001; 184:1594-7.
14. Meng XJ, Wiseman B, Elvinger F, et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 2002; 40:117-22.
15. Atiq M, Shire NJ, Barrett A, et al. Hepatitis E virus antibodies in patients with chronic liver disease. Emerg Infect Dis 2009; 15:479-81.
16. Faramawi MF, Johnson E, Chen S, et al. The incidence of hepatitis E virus infection in the general population of the USA. Epidemiol Infect 2011; 139:1145-50.
17. Drobeniuc J, Greene-Montfort T, Le NT, et al. Laboratory-based surveillance for hepatitis E virus infection, United States, 2005-2012. Emerg Infect Dis 2013; 19:218-22.
18. Crum-Cianflone NF, Curry F, Drobeniuc J, et al. Hepatitis E virus infection in HIV-infected persons. Emerg Infect Dis 2012; 18: 502-6.
19. Davern TJ, Chalsani N, Fontana RJ, et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastro-enterology 2011; 141:1665-72.e1-9.
20. Yoo N, Bernstein J, Caldwell C, et al. Hepatitis E virus infection in a liver transplant recipient: delayed diagnosis due to variable performance of serologic assay. Transpl Infect Dis 2013; 15:166-9.
21. Te HS, Drobeniuc J, Kamili S, et al. Hepatitis E virus infection in a liver transplant recipient in the United States: a case report. Transplant Proc 2013; 45:810-3.
22. Mast EE, Alter MJ, Holland PV, et al. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology 1998; 27:857-61.
23. Mansuy JM, Legrand-Abravanel F, Calot JP, et al. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol 2008; 80:289-93.
24. Christensen PB, Engle RE, Hjort C, et al. Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin Infect Dis 2008; 47:1026-31.
25. Bendall R, Ellis V, Ijaz S, et al. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV seroprevalence data in developed countries. J Med Virol 2010; 82:799-805.
26. Drobeniuc J, Meng J, Reuter G, et al. Serologic assays specific to immu-noglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010; 51:e24-7.
27. Verhoef L, Koopmans M, Duizer E, Bakker J, Reimerink J, Van Pelt W. Seroprevalence of hepatitis E antibodies and risk profile of HEV sero-positivity in The Netherlands, 2006-2007. Epidemiol Infect 2012; 140:1838-47.
28. Wenzel JJ, Preiss J, Schemmerer M, et al. Test performance characteristics of anti-HEV IgG assays strongly influence hepatitis E seropreva-lence estimates. Clin Infect Dis 2013; 207:497-500.
29. Ijaz S, Vyse AJ, Morgan D, Pebody RG, Tedder RS, Brown D. Indigenous hepatitis E virus infection in England: more common than it seems. J Clin Virol 2009; 44:272-6.
30. Khuroo MS, Khuroo MS. Seroepidemiology of a second epidemic of hepatitis E in a population that had recorded first epidemic 30 years before and has been under surveillance since then. Hepatol Int 2010; 4:494-9.